FKBP5 and Parkinson disease: Both bisphenols affected pathways such as “PARK2/PINK1/UCHL1 in Young Onset Parkinson’s Disease”, “TNF activation of NF-kB Expression Targets”, and “Androgen Receptor/FKBP5 Signaling”.